In clinical trials, there is potential to improve precision and reduce the required sample size by appropriately adjusting for baseline variables in the statistical analysis. This is called covariate adjustment. Despite recommendations by regulatory agencies in favor of covariate adjustment, it remains underutilized leading to inefficient trials. We address two obstacles that make it challenging to use covariate adjustment. A first obstacle is the incompatibility of many covariate adjusted estimators with commonly used boundaries in group sequential designs (GSDs). A second obstacle is the uncertainty at the design stage about how much precision gain will result from covariate adjustment. We propose a method that modifies the original estimator so that it becomes compatible with GSDs, while increasing or leaving unchanged the estimator's precision. Our approach allows the use of any asymptotically linear estimator, which covers many estimators used in randomized trials. Building on this, we propose using an information adaptive design, that is, continuing the trial until the required information level is achieved. Such a design adapts to the amount of precision gain and can lead to faster, more efficient trials, without sacrificing validity or power. We evaluate estimator performance in simulations that mimic features of a completed stroke trial.
翻译:在临床试验中,有可能通过在统计分析中适当调整基准变量来提高精确度和减少所需的抽样规模。这称为共变调整。尽管监管机构建议采用共变调整,但仍没有充分利用,导致低效试验。我们解决了两个障碍,这些障碍使得它难以使用共变调整。第一个障碍是许多在群组顺序设计中常用边界的共变调整估算器的不兼容性。第二个障碍是设计阶段对共变调整将产生多少精确收益的不确定性。我们建议了一种方法,即修改原估计器,使之与GSD兼容,同时增加或保留估计器的精确度不变。我们的方法允许使用任何非静变线性估计器,它涵盖在随机试验中使用的许多估算器。在此基础上,我们建议使用一种适应性信息的设计,即继续试验,直到达到所要求的信息水平。这种设计能够适应精确收益的数量,并导致更快、更有效率的测试,同时不牺牲模拟性能或力性能。我们估计的是,在模拟中,我们建议使用一种不牺牲性能或性能的模拟。我们建议使用一种适应性能。